Peer-reviewedCC BY 4.0Frontiers in Endocrinology
Editorial: Cancer risk in patients with acromegaly – is extensive screening needed?, volume II
- 1Department of Endocrinology, Aalborg University Hospital
- 2Steno Diabetes Center North Jutland
- 3Carol Davila University of Medicine and Pharmacy
Related
- Editorial: The insights of multi-omics into the microenvironment after tumor metastasis: a paradigm shift in molecular targeting modeling and immunotherapy for advanced cancer patients, volume II
- A Retrospective Study of the Efficacy and Safety of Chemoimmunotherapy in Elderly Patients with Extensive-Stage Small Cell Lung Cancer.
- Combined Use of Clinician Prediction of Survival and the Palliative Prognostic Index for Short‐Term Mortality Screening in Advanced Cancer Patients in an Acute Care Hospital
- Predictive markers of response and toxicity to tarlatamab in patients with extensive stage small cell lung cancer: a multi-institutional real-world analysis
- Preoperative HbA1c and postoperative day 1 fasting plasma glucose are associated with early glycemic improvement after transsphenoidal surgery in patients with acromegaly and preoperative dysglycemia: a retrospective cohort study.
BibTeX
@article{dal2026editorial,
title = {{Editorial: Cancer risk in patients with acromegaly – is extensive screening needed?, volume II}},
author = {Jakob Dal and Raluca Alexandra Trifanescu},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.2004968},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.2004968/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Editorial: Cancer risk in patients with acromegaly – is extensive screening needed?, volume II
AU - Jakob Dal
AU - Raluca Alexandra Trifanescu
PY - 2026
DA - 2026/10/09
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.2004968
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.2004968/full
SN - 1664-2392
ER -